《变应性鼻炎及其对哮喘的影响：2016年更新版》：在整个生命周期中，针对鼻炎和哮喘的预测医学实施新兴技术的护理路径。
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle.
作者信息
Bousquet J, Hellings P W, Agache I, Bedbrook A, Bachert C, Bergmann K C, Bewick M, Bindslev-Jensen C, Bosnic-Anticevitch S, Bucca C, Caimmi D P, Camargos P A M, Canonica G W, Casale T, Chavannes N H, Cruz A A, De Carlo G, Dahl R, Demoly P, Devillier P, Fonseca J, Fokkens W J, Guldemond N A, Haahtela T, Illario M, Just J, Keil T, Klimek L, Kuna P, Larenas-Linnemann D, Morais-Almeida M, Mullol J, Murray R, Naclerio R, O'Hehir R E, Papadopoulos N G, Pawankar R, Potter P, Ryan D, Samolinski B, Schunemann H J, Sheikh A, Simons F E R, Stellato C, Todo-Bom A, Tomazic P V, Valiulis A, Valovirta E, Ventura M T, Wickman M, Young I, Yorgancioglu A, Zuberbier T, Aberer W, Akdis C A, Akdis M, Annesi-Maesano I, Ankri J, Ansotegui I J, Anto J M, Arnavielhe S, Asarnoj A, Arshad H, Avolio F, Baiardini I, Barbara C, Barbagallo M, Bateman E D, Beghé B, Bel E H, Bennoor K S, Benson M, Białoszewski A Z, Bieber T, Bjermer L, Blain H, Blasi F, Boner A L, Bonini M, Bonini S, Bosse I, Bouchard J, Boulet L P, Bourret R, Bousquet P J, Braido F, Briggs A H, Brightling C E, Brozek J, Buhl R, Bunu C, Burte E, Bush A, Caballero-Fonseca F, Calderon M A, Camuzat T, Cardona V, Carreiro-Martins P, Carriazo A M, Carlsen K H, Carr W, Cepeda Sarabia A M, Cesari M, Chatzi L, Chiron R, Chivato T, Chkhartishvili E, Chuchalin A G, Chung K F, Ciprandi G, de Sousa J Correia, Cox L, Crooks G, Custovic A, Dahlen S E, Darsow U, Dedeu T, Deleanu D, Denburg J A, De Vries G, Didier A, Dinh-Xuan A T, Dokic D, Douagui H, Dray G, Dubakiene R, Durham S R, Du Toit G, Dykewicz M S, Eklund P, El-Gamal Y, Ellers E, Emuzyte R, Farrell J, Fink Wagner A, Fiocchi A, Fletcher M, Forastiere F, Gaga M, Gamkrelidze A, Gemicioğlu B, Gereda J E, van Wick R Gerth, González Diaz S, Grisle I, Grouse L, Gutter Z, Guzmán M A, Hellquist-Dahl B, Heinrich J, Horak F, Hourihane J O' B, Humbert M, Hyland M, Iaccarino G, Jares E J, Jeandel C, Johnston S L, Joos G, Jonquet O, Jung K S, Jutel M, Kaidashev I, Khaitov M, Kalayci O, Kalyoncu A F, Kardas P, Keith P K, Kerkhof M, Kerstjens H A M, Khaltaev N, Kogevinas M, Kolek V, Koppelman G H, Kowalski M L, Kuitunen M, Kull I, Kvedariene V, Lambrecht B, Lau S, Laune D, Le L T T, Lieberman P, Lipworth B, Li J, Lodrup Carlsen K C, Louis R, Lupinek C, MacNee W, Magar Y, Magnan A, Mahboub B, Maier D, Majer I, Malva J, Manning P, De Manuel Keenoy E, Marshall G D, Masjedi M R, Mathieu-Dupas E, Maurer M, Mavale-Manuel S, Melén E, Melo-Gomes E, Meltzer E O, Mercier J, Merk H, Miculinic N, Mihaltan F, Milenkovic B, Millot-Keurinck J, Mohammad Y, Momas I, Mösges R, Muraro A, Namazova-Baranova L, Nadif R, Neffen H, Nekam K, Nieto A, Niggemann B, Nogueira-Silva L, Nogues M, Nyembue T D, Ohta K, Okamoto Y, Okubo K, Olive-Elias M, Ouedraogo S, Paggiaro P, Pali-Schöll I, Palkonen S, Panzner P, Papi A, Park H S, Passalacqua G, Pedersen S, Pereira A M, Pfaar O, Picard R, Pigearias B, Pin I, Plavec D, Pohl W, Popov T A, Portejoie F, Postma D, Poulsen L K, Price D, Rabe K F, Raciborski F, Roberts G, Robalo-Cordeiro C, Rodenas F, Rodriguez-Mañas L, Rolland C, Roman Rodriguez M, Romano A, Rosado-Pinto J, Rosario N, Rottem M, Sanchez-Borges M, Sastre-Dominguez J, Scadding G K, Scichilone N, Schmid-Grendelmeier P, Serrano E, Shields M, Siroux V, Sisul J C, Skrindo I, Smit H A, Solé D, Sooronbaev T, Spranger O, Stelmach R, Sterk P J, Strandberg T, Sunyer J, Thijs C, Triggiani M, Valenta R, Valero A, van Eerd M, van Ganse E, van Hague M, Vandenplas O, Varona L L, Vellas B, Vezzani G, Vazankari T, Viegi G, Vontetsianos T, Wagenmann M, Walker S, Wang D Y, Wahn U, Werfel T, Whalley B, Williams D M, Williams S, Wilson N, Wright J, Yawn B P, Yiallouros P K, Yusuf O M, Zaidi A, Zar H J, Zernotti M E, Zhang L, Zhong N, Zidarn M
机构信息
Montpellier University Hospital, Montpellier, France ; MACVIA-France, Contre les MAladies Chroniques pour un VIeillissement Actif en France, European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France ; INSERM, U1168, Ageing and Chronic Diseases Epidemiological and Public Health Approaches, 94800 Villejuif, France ; CHRU Arnaud de Villeneuve, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France.
Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven, Louvain, Belgium.
出版信息
Clin Transl Allergy. 2016 Dec 30;6:47. doi: 10.1186/s13601-016-0137-4. eCollection 2016.
The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization workshop in 1999. The initial goals were (1) to propose a new allergic rhinitis classification, (2) to promote the concept of multi-morbidity in asthma and rhinitis and (3) to develop guidelines with all stakeholders that could be used globally for all countries and populations. ARIA-disseminated and implemented in over 70 countries globally-is now focusing on the implementation of emerging technologies for individualized and predictive medicine. MASK [MACVIA ()-ARIA Sentinel NetworK] uses mobile technology to develop care pathways for the management of rhinitis and asthma by a multi-disciplinary group and by patients themselves. An app (Android and iOS) is available in 20 countries and 15 languages. It uses a visual analogue scale to assess symptom control and work productivity as well as a clinical decision support system. It is associated with an inter-operable tablet for physicians and other health care professionals. The scaling up strategy uses the recommendations of the European Innovation Partnership on Active and Healthy Ageing. The aim of the novel ARIA approach is to provide an active and healthy life to rhinitis sufferers, whatever their age, sex or socio-economic status, in order to reduce health and social inequalities incurred by the disease.
变应性鼻炎及其对哮喘的影响（ARIA）倡议始于1999年世界卫生组织举办的一次研讨会。最初的目标是：（1）提出一种新的变应性鼻炎分类法；（2）推广哮喘和鼻炎共病的概念；（3）与所有利益相关者共同制定可在全球所有国家和人群中使用的指南。现已在全球70多个国家传播并实施的ARIA，目前正专注于个性化和预测性医学新兴技术的实施。MASK[法国变应性鼻炎和哮喘控制计划（MACVIA）-ARIA哨点网络]利用移动技术，由多学科团队以及患者自身制定鼻炎和哮喘管理的护理路径。一款应用程序（适用于安卓和iOS系统）在20个国家以15种语言推出。它使用视觉模拟评分法来评估症状控制情况和工作效率，还设有临床决策支持系统。它与一款供医生和其他医护专业人员使用的可互操作平板电脑相关联。扩大规模战略采用了欧洲积极和健康老龄化创新伙伴关系的建议。新型ARIA方法的目标是，无论年龄、性别或社会经济地位如何，都要为鼻炎患者提供积极健康的生活，以减少该疾病造成的健康和社会不平等。
Zotero 插件